营收表现强劲，股东回报优厚，尿素短期及长期前景向好

Revenue and Earnings Performance - Fertiglobe reported Q2 2025 revenue of $566 million, exceeding consensus expectations of $509 million by 11%[5] - Adjusted net income for Q2 2025 was approximately $12 million, falling short of the consensus estimate of $20 million by 42%[5] - The company's EBITDA margin for Q2 2025 was 31%, down from 38% in Q1 2025[5] Dividend and Share Buyback Plans - Fertiglobe announced a dividend of 4.4 fils per share for the first half of 2025, down from 6.6 fils in the same period of 2024[1] - The company plans a stock buyback program worth $31 million[1] Strategic Goals and Market Outlook - Fertiglobe reiterated its strategic goal of achieving over $1 billion in EBITDA by 2030[2] - The company highlighted a tight supply in the urea market, expecting limited supply growth to support prices in the long term[1] Cost Management and Capital Expenditure - The company aims to achieve annual interest savings of $10 million and expects to realize cost savings between $15 million and $21 million by year-end[3] - Capital expenditures for Q2 2025 were reported at $42 million, with maintenance capital expenditures projected to remain at the lower end of the previous guidance range of $145 million to $170 million per year[2] Risks and Challenges - Key risks include potential oversupply, fertilizer price declines, project delays, and acceptance of low-carbon products by customers[4]